Diabetes Pathogenesis
Degree of microalbuminuria is a determinant of erythropoietin in type 2 diabetes mellitus
Published in Blood Weekly, September 28th, 2006
"Low plasma erythropoeitin (EPO) is a key causal factor in the anaemia of diabetic patients. The aim of this study was to investigate the prevalence of anaemia in relation to EPO in patients with type 2 diabetes," researchers in Kuwait report.
O.A. Mojiminiyi and colleagues at Kuwait University described, "In a clinic-based cross-sectional study of 161 type 2 diabetes patients, we measured EPO, ferritin and full blood count. The patients were classified on the basis of the urine albumin:creatinine excretion ratio as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-09-28)
More Articles from Blood Weekly
- Blood Banking
Pall EBDS system detects bacteria in red blood cells - Blood Banking
Platelet binding and phagocytosis by macrophages is reduced using metabolic arrest - Blood Banking
Several factors affect bone marrow volume reduction and red blood cell depletion prior to transplant - Blood Transfusion
Efficacy of shipped HLA-matched platelets is reported - Leukapheresis
Leukapheresis under anesthesia safe and feasible in very low-weight noncompliant children - Acute Myeloid Leukemia
Leukemia linked to expression of B cell-specific activator protein - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
